Navigation Links
SETO Holdings, Inc. Signs Agreement to Acquire Advanced Hearing Centers, Inc. and Will Dispose of All Existing Business; New Management to be Installed

BRIARCLIFF MANOR, N.Y., May 18 /PRNewswire-FirstCall/ -- SETO Holdings, Inc. (Pink Sheets: SETO) announced that it signed a definitive agreement to acquire from Sanjay Srivastava 100% of the capital stock of Advanced Hearing Centers, Inc. ("AHC"), a Maryland corporation formed in 2004 which provides hearing services and retails hearing aids from 11 locations in Maryland and one in Virginia. It is a condition to the closing of the AHC acquisition that the public company shall sell all of SETO's current businesses, i.e., industrial ceramics fabrication and contract manufacturing, to Eugene Pian, SETO's President, in exchange for all the shares of SETO Common Stock he owns, and that Mr. Pian will resign as an officer and director and cease all affiliation with the public company.

The closing is expected to take place on or about May 22, 2009. Following the closing there will be issued and outstanding 77,923,120 shares of the public company's Common Stock, of which the public shareholders will continue to own 7,792,312 shares, or 10% thereof. Sanjay Srivastava, AHC's founder and CEO, will become the owner of 90% of the outstanding Common Stock of the public company and he will become President and CEO of the public company.

The public company will schedule a conference call after the closing to existing and new shareholders. On this call Mr. Srivastava will discuss the public company's business and the forward looking goals of AHC. You also now can go to AHC's web site ( or contact Richard Kepler, AHC's Director of Investor Relations, at 410-440-9700.

The public company intends to seek to raise additional capital through a private placement, using the proceeds to help finance expansion of AHC's hearing centers. In addition Mr. Srivastava intends to obtain the necessary audited financial statements and have the public company again make appropriate filings with the Securities Exchange Commission and become subject to the reporting requirements of federal securities laws.

Forward-Looking Statements: Statements in this new release regarding future financial and operating results, future expansion and growth, opportunities for the public company and any other statements about its future expectations, beliefs, goals, plans, or prospects constitute forward-looking statements within the meaning of the private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements, There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital and economic conditions generally. Forward-looking statements are based on the beliefs, opinions, and expectations of management at the time they are made, and the public company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

SOURCE SETO Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LifeCare Holdings, Inc. Announces First Quarter Results
2. China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates
3. Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting
4. China Pharma Holdings, Inc. to Report First Quarter 2009 Financial Results on May 15, 2009
5. Duane Reade Holdings, Inc. Reports First Quarter 2009 Results
6. China Pharma Holdings, Inc. Retains Global Investor Communications Team
7. China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member
8. JAG Media Holdings, Inc. Announces Update of the Status of its Proposed Acquisition of CardioGenics Inc.
9. Innophos Holdings, Inc. Schedules Call to Discuss First Quarter 2009 Results
10. Zimmer Holdings, Inc. Reports First Quarter 2009 Financial Results
11. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Second Quarter Earnings Webcast
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley ... Michigan boxing style concert posters. This is one of Joplin's most famous and beautiful ... at the University of Michigan in Ann Arbor. The According to Hawley, "It is ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at ... Michigan, have come together on Thanksgiving Day to share the things that they ... on the Serenity Point YouTube channel, patients displayed what they wrote on index ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... , ... November 26, 2015 , ... PRMA Plastic Surgery ... 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What ... up every day excited to rebuild lives and it’s an honor to have served ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... , Nov. 25, 2015 On Tuesday, ... federal bellwether trial against Wright Medical Technology, Inc. ... their Conserve metal-on-metal hip implant device, awarded $11 ... a two week trial and three days of ... hip device was defectively designed and unreasonably dangerous, ...
Breaking Medicine Technology: